Old Web
English
Sign In
Acemap
>
authorDetail
>
Gregg Olsen
Gregg Olsen
Providence Saint Joseph Medical Center
Brentuximab vedotin
Medicine
Internal medicine
Lymphoma
Dacarbazine
3
Papers
136
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term follow-up of brentuximab vedotin ± dacarbazine as first line therapy in elderly patients with Hodgkin lymphoma.
2018
Journal of Clinical Oncology
Jonathan W. Friedberg
Andres Forero-Torres
Beata Holkova
Jerome H. Goldschmidt
Ralph V. Boccia
Rodolfo Bordoni
Vivian Jean M. Cline
Dipti Patel-Donnelly
Patrick J. Flynn
Gregg Olsen
Robert Chen
Faith Galderisi
Yinghui Wang
Jeff Porter Sharman
Christopher A. Yasenchak
Show All
Source
Cite
Save
Citations (2)
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
2017
Blood
Jonathan W. Friedberg
Andres Forero-Torres
Rodolfo E Bordoni
Vivian Jean M. Cline
Dipti Patel-Donnelly
Patrick J. Flynn
Gregg Olsen
Robert Chen
Abraham Fong
Yinghui Wang
Christopher A. Yasenchak
Show All
Source
Cite
Save
Citations (45)
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older
2015
Blood
Andres Forero-Torres
Beata Holkova
Jerome H. Goldschmidt
Robert Chen
Gregg Olsen
Ralph V. Boccia
Rodolfo E Bordoni
Jonathan W. Friedberg
Jeff P. Sharman
Maria Corinna Palanca-Wessels
Yinghui Wang
Christopher A. Yasenchak
Show All
Source
Cite
Save
Citations (89)
1